A review of Epstein-Barr virus infection in patients with immunodeficiency disorders

American Journal of the Medical Sciences

Volumn 319, Issue 6, 2000, Pages 392-396

  Okano, Motohiko ^a   Gross, Thomas G ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Epstein Barr virus (EBV) infection; Immunodeficiency diseases

Indexed keywords

DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; ORGAN TRANSPLANTATION; REVIEW; VIRUS INFECTION;

EID: 0034131028     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40780-3     Document Type: Review

References (30)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964;i:702-3.
2. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968;59:94-101.
3. Old LJ, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci USA 1966;56:1699-704.
4. Purtilo DT, Cassel CK, Yang JPS, et al. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975;i:935-41.
5. Joncas J, LaPointe N, Gervais F, et al. Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibody in ataxia-telangiectasia. J Immunol 1977;119:1857-9.
6. Saemundsen AK, Berkel AI, Henle W, et al. Epstein-Barr virus carrying lymphoma in a patient with ataxia telangiectasia. Brit Med J 1981;282:425-7.
7. Okano M, Mizuno F, Osato T, et al. Wiskott-Aldrich syndrome and Epstein-Barr virus-induced lymphoproliferation. Lancet 1984;ii:933-4.
8. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981;41:4253-61.
9. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine A-prednisolone immunosuppression. Lancet 1984;1(8377):583-7.
10. Beral V, Peterman T, Berkelman R, et al. AIDS-associated non-Hodgkin lymphoma. Lancet 1991;337:805-9.
11. Okano M. Epstein-Barr virus infection and its role in the expanding spectrum of human diseases. Acta Paediatr 1998; 87:11-8.
12. Liebowitz D, Kieff E. Epstein-Barr virus. In: Roizman B, Whitley RJ, Lopez C, editors. The human herpesviruses. New York: Raven Press; 1993. p. 107-72.
13. Habeshaw G, Yao QY, Bell AI, et al. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J Virol 1999;73:965-75.
14. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 1998;338:1413-21.
15. Rosen FS, Wedgwood RJP, Eibl M, et al. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin Exp Immunol 1997;109(Suppl 1):1-28.
16. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-53.
17. Berkel AI, Henle W, Henle G, et al. Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia. Clin Exp Immunol 1979;35:196-201.
18. Okano M, Sakiyama Y, Matsumoto S, et al. A serological study of Epstein-Barr virus infection in Japanese patients with ataxia telangiectasia. Immunol Infect Dis 1994;4:65-8.
19. Derry JMJ, Ochs HD, Franke U. Isolation of a novel gene mutated Wiskott-Aldrich syndrome. Cell 1994;78:635-44.
20. Nakanishi M, Kikuta H, Tomizawa K, et al. Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome. Cancer 1993;72:1376-81.
21. Barbosa MDFS, Nguyen QA, Tcherner VT, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996;382:262-5.
22. Merino F, Klein G, Henle W, et al. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome. Clin Immunol Immunopathol 1983;27:326-39.
23. Elenitba-Johnson KS, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1997;14:35-47.
24. Mieraw GW, Greffe BS, Weeks DA. Primary leiomyosarcoma of brain in adolescent with common variable immunodeficiency syndrome. Ultrastruct Pathol 1997;21:301-5.
25. Okano M. Therapeutic approaches for severe Epstein-Barr virus infection. Pediatr Hematol Oncol 1997;14:109-19.
26. Sayos J, Wu C, Morra M, et al. The X-linked lymphoproliferative disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998;395:462-9.
27. Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998;20:129-35.
28. Nichols KE, Harkin DP, Levitz S, et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1998; 95:13765-70.
29. Uccinis S, Monardo F, Ruco LP, et al. High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease. Lancet 1989;1(8652):1458.
30. Okano M, Mizuno F, Aya T, et al. Epstein-Barr virus hypersensitivity of lymphocytes from patients with ataxia telangiectasia. Int J Oncol 1993;2:1027-31.